Literature DB >> 6609033

Disorders of regulatory T cell function in patients with the Wiskott-Aldrich syndrome.

J M Zabay, G Fontán, A Campos, M C García-Rodriguez, D Pascual-Salcedo, A Bootello, E G de la Concha.   

Abstract

Three patients with the Wiskott-Aldrich syndrome were studied. One of them had no past history of relevant infections. The other two presented different degrees of humoral and cellular immunodeficiency and their T cells in vitro showed a defect in regulatory activity of Ig production in PWM stimulated cultures. This defect was not observed in the third patient. All three had normal numbers of B cells, producing normal amounts of Ig in vitro when co-cultured with normal T cells. It is suggested that the immunoregulatory T cell abnormality might play an important role in the pathogenesis of the humoral immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609033      PMCID: PMC1535968     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Immunoglobulins and transient paraproteins in sera of patients with the Wiskott-Aldrich syndrome: a follow-up study.

Authors:  J Radl; L H Dooren; A Morell; F Skvaril; J M Vossen; C H Uittenbogaart
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

2.  Lymphocyte-macrophage interaction in antigen induced in vitro lymphocyte transformation in patients with the Wiskott-Aldrich syndrome and other diseases with anergy.

Authors:  R M Blaese; J J Oppenheim; R C Seeger; T A Waldmann
Journal:  Cell Immunol       Date:  1972-07       Impact factor: 4.868

3.  The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition.

Authors:  R M Blaese; W Strober; R S Brown; T A Waldmann
Journal:  Lancet       Date:  1968-05-18       Impact factor: 79.321

4.  Attenuated form of Wiskott-Aldrich syndrome.

Authors:  C A Amaya; S Dorantes; A H Toro; A Bello; J Cuëllar
Journal:  J Pediatr       Date:  1973-01       Impact factor: 4.406

Review 5.  Maturation of B-cell differentiation ability and T-cell regulatory function in infancy and childhood.

Authors:  T Miyawaki; N Moriya; T Nagaoki; N Taniguchi
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

6.  The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets.

Authors:  H D Ochs; S J Slichter; L A Harker; W E Von Behrens; R A Clark; R J Wedgwood
Journal:  Blood       Date:  1980-02       Impact factor: 22.113

7.  Decline in suppressor T cell function with age in female NZB mice.

Authors:  D R Barthold; S Kysela; A D Steinberg
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

8.  Activation of human B lymphocytes. IV. Regulatory effects of corticosteroids on the triggering signal in the plaque-forming cell response of human peripheral blood B lymphocytes to polyclonal activation.

Authors:  A S Fauci; K R Pratt; G Whalen
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

9.  Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.

Authors:  R Parkman; J Rappeport; R Geha; J Belli; R Cassady; R Levey; D G Nathan; F S Rosen
Journal:  N Engl J Med       Date:  1978-04-27       Impact factor: 91.245

10.  Allelic exclusion of glucose-6-phosphate dehydrogenase in platelets and T lymphocytes from a Wiskott-Aldrich syndrome carrier.

Authors:  W J Gealy; J M Dwyer; J B Harley
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

View more
  4 in total

1.  A novel X-linked combined immunodeficiency disease.

Authors:  E G Brooks; F C Schmalstieg; D P Wirt; H M Rosenblatt; L T Adkins; D P Lookingbill; H E Rudloff; T A Rakusan; A S Goldman
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

2.  Defective B-cell and regulatory T-cell function in Wiskott-Aldrich syndrome.

Authors:  Y L Lau; B M Jones; L C Low; S N Wong; N K Leung
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

3.  Anticardiolipin antibodies in patients with primary immunodeficiency diseases.

Authors:  D Pascual-Salcedo; M C García Rodríguez; M López Trascasa; G Fontán
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

Review 4.  Wiskott-Aldrich syndrome: new perspectives in pathogenesis and management.

Authors:  G R Standen
Journal:  J R Coll Physicians Lond       Date:  1988-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.